{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:16Z","timestamp":1786986916455,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clcc.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:15:47Z","timestamp":1758068147000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant Treatment"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-4827","authenticated-orcid":false,"given":"Jelle A.","family":"Nieuwstraten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline G.M.","family":"van Geffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn W.H.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd S.","family":"Aukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clcc.2025.09.001_bib0002","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2025.09.001_bib0003","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.clcc.2025.09.001_bib0004","first-page":"917","article-title":"Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level","volume":"10","author":"Samowitz","year":"2001","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"24","key":"10.1016\/j.clcc.2025.09.001_bib0005","first-page":"5849","article-title":"Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history","volume":"53","author":"Lothe","year":"1993","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.clcc.2025.09.001_bib0006","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/91.15.1295","article-title":"Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers","volume":"91","author":"Halling","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.clcc.2025.09.001_bib0007","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cam4.5076","article-title":"The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency","volume":"12","author":"Yunlong","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.clcc.2025.09.001_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12885-024-11821-w","article-title":"The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study","volume":"24","author":"Liao","year":"2024","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.clcc.2025.09.001_bib0009","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2025.09.001_bib0010","first-page":"1763","article-title":"Microsatellite instability and survival in rectal cancer","volume":"20","author":"Samowitz","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.clcc.2025.09.001_bib0011","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/his.14710","article-title":"Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature","volume":"81","author":"Swets","year":"2022","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.clcc.2025.09.001_bib0012","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/SLA.0000000000003051","article-title":"Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: a National Cancer Database (NCDB) analysis","volume":"271","author":"Hasan","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.clcc.2025.09.001_bib0013","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4174\/astr.2022.103.3.176","article-title":"Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"103","author":"Lee","year":"2022","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.clcc.2025.09.001_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.suronc.2020.03.009","article-title":"Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis","volume":"34","author":"O\u2019Connell","year":"2020","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2025.09.001_bib0015","first-page":"188","article-title":"Incidence and outcomes of patients with mismatch repair deficient rectal cancer operated in 2016: a nationwide cohort from the Netherlands","volume":"24","author":"van Geffen","year":"2025","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.clcc.2025.09.001_bib0017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejso.2022.10.018","article-title":"Neoadjuvant immunotherapy for dMMR\/MSI-H locally advanced rectal cancer: the future new standard approach?","volume":"49","author":"Cabezon-Gutierrez","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"25","key":"10.1016\/j.clcc.2025.09.001_bib0018","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clcc.2025.09.001_bib0019","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clcc.2025.09.001_bib0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bjs.9112","article-title":"Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer","volume":"100","author":"Sloothaak","year":"2013","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.clcc.2025.09.001_bib0021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.clcc.2025.09.001_bib0022","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2025.09.001_bib0023","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/s41591-024-03250-w","article-title":"Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial","volume":"15","author":"de Gooyer","year":"2024","journal-title":"Nat Med."},{"issue":"3","key":"10.1016\/j.clcc.2025.09.001_bib0024","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","article-title":"Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study","volume":"36","author":"Andr\u00e9","year":"2025","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2025.09.001_bib0025","first-page":"325","article-title":"A phase two, single-arm, open-label study with Dostarlimab monotherapy in participants with untreated stage II\/III dMMR\/MSI-H locally advanced rectal cancer (AZUR-1)","volume":"24","author":"Cercek","year":"2025","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"10.1016\/j.clcc.2025.09.001_bib0026","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1120009X.2022.2162220","article-title":"Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer","volume":"35","author":"Liu","year":"2023","journal-title":"J Chemother"},{"issue":"10476","key":"10.1016\/j.clcc.2025.09.001_bib0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","article-title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial","volume":"405","author":"Andr\u00e9","year":"2025","journal-title":"The Lancet"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002825000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T12:22:57Z","timestamp":1763814177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002825000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1533002825000751"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2025.09.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}